Dmitry Balyasny
HELP

Dmitry Balyasny’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Dmitry Balyasny’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Buy
+191,193
New +$956K ﹤0.01% 2080

Other funds holding HELP

VR Adviser
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Rosalind Advisors
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Sphera Funds Management
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Sio Capital Management
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Nan Fung Group Holdings
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Dmitry Balyasny's HELP Position: Q2 2026 in Review

Dmitry Balyasny opened a new position in Helus Pharma Inc. Common Stock (HELP) in Q2 2026: 191,193 shares worth $1.26M. The stake represents ﹤0.01% of the portfolio and ranks #2080 among its holdings.

99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Dmitry Balyasny held 191,193 shares of Helus Pharma Inc. Common Stock worth $1.26M as of Q2 2026.
  • Helus Pharma Inc. Common Stock was a new Dmitry Balyasny position in Q2 2026.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2080 holding.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.